TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel

Executive Summary

• TempraMed Technologies announced the first commercial sales of its VIVI product line to pharmacies operated by Israel’s Maccabi Healthcare Services.
• A nationwide in‑pharmacy marketing campaign has been launched across Maccabi’s network, making the products available at point‑of‑care for over 2.8 million insured members.
• The rollout is presented as a key operational milestone that expands TempraMed’s institutional channel footprint and supports its broader growth strategy.

Key Details

• Products Sold: VIVI Cap, VIVI Cap Smart, VIVI Epi, and VIVI Med.
• Customer/Partner: Maccabi Healthcare Services (Israel’s second‑largest HMO).
• Coverage: Initial sales to Maccabi pharmacies; national marketing campaign to place products on shelves across the entire pharmacy network.
• Target Population: Over 2.8 million insured members served by Maccabi.
• Commercial Significance: First time TempraMed’s products will be sold directly to end‑customers in store and online within a large healthcare system, demonstrating ability to execute at scale.
• Strategic Impact: Expected to drive recurring demand, strengthen brand presence in institutional channels, and serve as a platform for expansion into additional HMOs, payors, and institutional partners both in Israel and internationally.
• CEO Quote (Ron Nagar): Highlights the milestone as proof of execution capability, growing demand for temperature‑protection solutions, and alignment with broader commercialization strategy.

Notable Quotes

“Shipping product and launching a nationwide campaign across the Maccabi brick‑and‑mortar pharmacy network demonstrates our ability to execute at scale within a large healthcare system.” – Ron Nagar, CEO, TempraMed Technologies Ltd.